Frontlight ResearchEarly access
Taking peopleNo phase
Swiss Primary Sclerosing Cholangitis Cohort Study
Key facts
- Who runs it
- Fondazione Epatocentro Ticino
- Where
- Switzerland21 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 28 Feb 2017
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 19 August 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
- patients living in Switzerland
Who cannot take part
- N/A
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Research project in which biological material is sampled and health-related personal data is further used and collected.
Read full original descriptionShow less
Coded data are used.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 19 August 2025